Brain atrophy measurements should be used to guide therapy monitoring in MS - NO

被引：16
作者：
Barkhof, Frederik [1 ,2 ,3 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, POB 7057, NL-1007 MB Amsterdam, Netherlands
[2] UCL, Inst Neurol, London, England
[3] UCL, Inst Biomed Engn, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷 / 12期
关键词：
REMITTING MULTIPLE-SCLEROSIS; MRI;
D O I：
10.1177/1352458516649452
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1524 / 1526
页数：4
相关论文
共 10 条
[1]   Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis? [J].
Azevedo, Christina J. ;
Pelletier, Daniel .
CURRENT OPINION IN NEUROLOGY, 2016, 29 (03) :237-242
[2]   Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis [J].
De Stefano, Nicola ;
Stromillo, Maria Laura ;
Giorgio, Antonio ;
Bartolozzi, Maria Letizia ;
Battaglini, Marco ;
Baldini, Mariella ;
Portaccio, Emilio ;
Amato, Maria Pia ;
Sormani, Maria Pia .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (01) :93-99
[3]   Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study [J].
Jacobsen, Cecilie ;
Hagemeier, Jesper ;
Myhr, Kjell-Morten ;
Nyland, Harald ;
Lode, Kirsten ;
Bergsland, Niels ;
Ramasamy, Deepa P. ;
Dalaker, Turi O. ;
Larsen, Jan Petter ;
Farbu, Elisabeth ;
Zivadinov, Robert .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10) :1109-1115
[4]   Inclusion of brain volume loss in a revised measure of "no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis [J].
Kappos, Ludwig ;
De Stefano, Nicola ;
Freedman, Mark S. ;
Cree, Bruce A. C. ;
Radue, Ernst-Wilhelm ;
Sprenger, Till ;
Sormani, Maria Pia ;
Smith, Terence ;
Haring, Dieter A. ;
Meier, Daniela Piani ;
Tomic, Davorka .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (10) :1297-1305
[5]   Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations [J].
Nakamura, Kunio ;
Brown, Robert A. ;
Narayanan, Sridar ;
Collins, D. Louis ;
Arnold, Douglas L. .
NEUROIMAGE, 2015, 118 :126-132
[6]   Combined analysis of global and compartmental brain volume changes in early multiple sclerosis in clinical practice [J].
Pichler, A. ;
Khalil, M. ;
Langkammer, C. ;
Pinter, D. ;
Bachmaier, G. ;
Ropele, S. ;
Fuchs, S. ;
Enzinger, C. ;
Fazekas, F. .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) :340-346
[7]   Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Disability in Multiple Sclerosis [J].
Sormani, Maria Pia ;
Arnold, Douglas L. ;
De Stefano, Nicola .
ANNALS OF NEUROLOGY, 2014, 75 (01) :43-49
[8]   Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy [J].
Vidal-Jordana, Angela ;
Sastre-Garriga, Jaume ;
Rovira, Alex ;
Montalban, Xavier .
JOURNAL OF NEUROLOGY, 2015, 262 (12) :2617-2626
[9]   Automated brain volumetrics in multiple sclerosis: a step closer to clinical application [J].
Wang, C. ;
Beadnall, H. N. ;
Hatton, S. N. ;
Bader, G. ;
Tomic, D. ;
Silva, D. G. ;
Barnett, M. H. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (07) :754-757
[10]   EVIDENCE-BASED GUIDELINES MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients [J].
Wattjes, Mike P. ;
Rovira, Alex ;
Miller, David ;
Yousry, Tarek A. ;
Sormani, Maria P. ;
de Stefano, Nicola ;
Tintore, Mar ;
Auger, Cristina ;
Tur, Carmen ;
Filippi, Massimo ;
Rocca, Maria A. ;
Fazekas, Franz ;
Kappos, Ludwig ;
Polman, Chris ;
Barkhof, Frederik ;
Montalban, Xavier .
NATURE REVIEWS NEUROLOGY, 2015, 11 (10) :597-606
1